Welcome
Support Centre
11 October 2008 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
A prospective randomised trial of adjuvant chemotherapy in node positive early stage carcinoma of the cervix
ISRCTN ISRCTN52711596
ClinicalTrials.gov identifier
Public title A prospective randomised trial of adjuvant chemotherapy in node positive early stage carcinoma of the cervix
Scientific title
Acronym N/A
Serial number at source CE3005
Study hypothesis Not provided at time of registration
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Cervix cancer
Participants - inclusion criteria 1. Histologically proven invasive adeno or squamous cell carcinoma of the cervix
2. Histologically proven pelvic lymph node involvement
3. Stage Ib or IIa disease
4. Fit to receive either treatment arm
5. Adequate renal hepatic and haematological function
6. Adequate pulmonary function
7. Patients with a probability of <0.2 of not developing severe encephalopathy with ifosfamide/mensa treatment are excluded
8. No second primary tumour other than basal cell carcinoma of the skin
9. No other serious medical or psychological condition precluding treatment
Participants - exclusion criteria Not provided at time of registration
Anticipated start date 01/01/1990
Anticipated end date 28/02/1996
Status of trial Completed
Patient information material
Target number of participants Not provided at time of registration
Interventions Following surgery patients are randomised to either:
1. Arm A: External beam pelvic radiotherapy
2. Arm B: Adjuvant chemotherapy plus external beam radiotherapy
Primary outcome measure(s) Not provided at time of registration
Secondary outcome measure(s) Not provided at time of registration
Sources of funding Cancer Research UK
Trial website
Publications
Contact name Dr  -  -
  Address UKCCCR Register Co-ordinator
MRC Clinical Trials Unit
222 Euston Road
  City/town London
  Zip/Postcode NW1 2DA
  Country United Kingdom
  Tel +44 (0) 20 7670 4723
  Fax +44 (0) 20 7670 4818
  Email register@ctu.mrc.ac.uk
Sponsor Cancer Research UK (CRUK) (UK)
  Address PO Box 123
Lincoln's Inn Fields
  City/town London
  Zip/Postcode WC2A 3PX
  Country United Kingdom
  Tel +44 (0)20 7317 5186
  Fax +44 (0)20 7487 4302
  Email kate.law@cancer.org.uk
  Sponsor website: http://www.cancer.org.uk
Date applied 01/07/2001
Last edited 23/05/2008
Date ISRCTN assigned 01/07/2001
Submit your trial protocol Top studies in medical research Submit to Trials journal
© ISRCTN


BioMed Central